- Home
- BHC vs PRGO Comparison
BHC vs PRGO Comparison
Compare BHC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- PRGO
- Stock Information
- Founded
- BHC N/A
- PRGO 1887
- Country
- BHC Canada
- PRGO Ireland
- Employees
- BHC N/A
- PRGO 9140
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- BHC Health Care
- PRGO Health Care
- Exchange
- BHC Nasdaq
- PRGO Nasdaq
- Market Cap
- BHC 3.0B
- PRGO 3.5B
- IPO Year
- BHC N/A
- PRGO 1991
- Fundamental
- Price
- BHC $7.43
- PRGO $25.76
- Analyst Decision
- BHC Hold
- PRGO Buy
- Analyst Count
- BHC 4
- PRGO 4
- Target Price
- BHC $7.25
- PRGO $37.00
- AVG Volume (30 Days)
- BHC 1.4M
- PRGO 1.3M
- Earning Date
- BHC 10-30-2024
- PRGO 11-06-2024
- Dividend Yield
- BHC N/A
- PRGO 4.29%
- EPS Growth
- BHC N/A
- PRGO N/A
- EPS
- BHC N/A
- PRGO N/A
- Revenue
- BHC $9,474,000,000.00
- PRGO $4,392,000,000.00
- Revenue This Year
- BHC $10.68
- PRGO N/A
- Revenue Next Year
- BHC $3.66
- PRGO $4.51
- P/E Ratio
- BHC N/A
- PRGO N/A
- Revenue Growth
- BHC 10.91
- PRGO N/A
- 52 Week Low
- BHC $3.96
- PRGO $23.89
- 52 Week High
- BHC $11.46
- PRGO $34.60
- Technical
- Relative Strength Index (RSI)
- BHC 37.99
- PRGO 36.42
- Support Level
- BHC $7.42
- PRGO $25.16
- Resistance Level
- BHC $7.79
- PRGO $28.62
- Average True Range (ATR)
- BHC 0.28
- PRGO 0.66
- MACD
- BHC -0.06
- PRGO -0.35
- Stochastic Oscillator
- BHC 8.40
- PRGO 15.79
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.